Bouvel Investment Partners, LLC Crispr Therapeutics Ag Transaction History

Bouvel Investment Partners, LLC

$267 Million
Q2 2025

A detailed history of Bouvel Investment Partners, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Bouvel Investment Partners, LLC holds 31,161 shares of CRSP stock, worth $1.76 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

31,161

Previous 21,703 43.58%

Holding current value

$1.76 Million

Previous $738,000 105.28%

% of portfolio

0.57%

Previous 0.33%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	BUY	$31.27 - $48.64 $295,751 - $460,037	9,458 Added 43.58%	31,161 $1.52 Million
Q1 2025 Apr 17, 2025	SELL	$34.03 - $53.02 $4,866 - $7,581	-143 Reduced 0.65%	21,703 $738,000
Q4 2024 Jan 14, 2025	BUY	$38.65 - $55.15 $5,526 - $7,886	143 Added 0.66%	21,846 $859,000
Q3 2024 Nov 05, 2024	SELL	$44.62 - $62.75 $10,217 - $14,369	-229 Reduced 1.04%	21,703 $1.02 Million
Q2 2024 Jul 12, 2024	BUY	$51.17 - $68.18 $204 - $272	4 Added 0.02%	21,932 $1.18 Million
Q1 2024 Apr 15, 2024	BUY	$60.67 - $89.12 $4,853 - $7,129	80 Added 0.37%	21,928 $1.49 Million
Q4 2023 Jan 11, 2024	BUY	$38.62 - $72.18 $36,380 - $67,993	942 Added 4.51%	21,848 $1.37 Million
Q3 2023 Oct 10, 2023	BUY	$45.39 - $59.0 $17,747 - $23,069	391 Added 1.91%	20,906 $948,000
Q2 2023 Jul 14, 2023	BUY	$43.47 - $67.77 $24,256 - $37,815	558 Added 2.8%	20,515 $1.15 Million
Q1 2023 Apr 11, 2023	BUY	$41.0 - $56.12 $23,329 - $31,932	569 Added 2.93%	19,957 $902,000
Q4 2022 Jan 18, 2023	BUY	$39.19 - $65.67 $25,943 - $43,473	662 Added 3.54%	19,388 $0
Q3 2022 Oct 13, 2022	BUY	$61.1 - $83.78 $11,609 - $15,918	190 Added 1.03%	18,726 $1.22 Million
Q2 2022 Jul 13, 2022	BUY	$43.23 - $73.83 $9,769 - $16,685	226 Added 1.23%	18,536 $1.13 Million
Q1 2022 Apr 11, 2022	BUY	$53.19 - $79.24 $7,712 - $11,489	145 Added 0.8%	18,310 $1.15 Million
Q4 2021 Jan 19, 2022	SELL	$70.09 - $111.29 $14,999 - $23,816	-214 Reduced 1.16%	18,165 $1.38 Million
Q3 2021 Oct 07, 2021	SELL	$110.2 - $156.64 $36,145 - $51,377	-328 Reduced 1.75%	18,379 $2.06 Million
Q2 2021 Jul 12, 2021	BUY	$100.84 - $161.89 $2,016 - $3,237	20 Added 0.11%	18,707 $3.03 Million
Q1 2021 Apr 16, 2021	SELL	$110.72 - $210.04 $11,404 - $21,634	-103 Reduced 0.55%	18,687 $2.28 Million
Q4 2020 Feb 02, 2021	BUY	$79.67 - $173.23 $1.5 Million - $3.25 Million	18,790 New	18,790 $2.88 Million

Others Institutions Holding CRSP

# of Institutions

504

Shares Held

66.9M

Call Options Held

2.16M

Put Options Held

2.13M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.42B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bouvel Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bouvel Investment Partners, LLC with notifications on news.

Account

Bouvel Investment Partners, LLC Crispr Therapeutics Ag Transaction History